Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BT
101
DELISTED
BT Group plc (ADR)
BT
| $78.4M | 0.19% |
2,482,600
-45,800
| -2% | -$1.37M |
|
102
Netflix
NFLX
$311B
| $76.8M | 0.18% |
14,609,000
-4,921,000
| -25% | -$24.1M |
|
103
Procter & Gamble
PG
$338B
| $75.9M | 0.18% |
932,529
-571,400
| -38% | -$46.6M |
|
|
BBBY
104
DELISTED
Bed Bath & Beyond Inc
BBBY
| $74.3M | 0.18% |
924,960
-152,200
| -14% | -$11.8M |
|
105
Vale
VALE
$60.9B
| $73.7M | 0.18% |
4,832,371
+2,128,471
| +79% | +$33.1M |
|
|
NTT
106
DELISTED
Nippon Telegraph & Telephone
NTT
| $73.2M | 0.18% |
2,706,300
+276,100
| +11% | +$7.25M |
|
107
Starbucks
SBUX
$122B
| $72.6M | 0.17% |
1,851,784
+541,384
| +41% | +$21.4M |
|
108
Perrigo
PRGO
$1.78B
| $72.4M | 0.17% |
471,810
+18,540
| +4% | +$2.67M |
|
109
Bio-Techne
TECH
$11.2B
| $72.1M | 0.17% |
3,048,000
-704,400
| -19% | -$15.3M |
|
110
Manhattan Associates
MANH
$11.4B
| $71.8M | 0.17% |
2,443,600
+253,600
| +12% | +$6.97M |
|
111
Flowers Foods
FLO
$1.52B
| $71M | 0.17% |
3,308,182
-489,700
| -13% | -$11.1M |
|
|
EMC
112
DELISTED
EMC CORPORATION
EMC
| $70.6M | 0.17% |
+2,806,000
| New | +$68M |
|
113
Synopsys
SNPS
$78.7B
| $70.6M | 0.17% |
1,739,434
+482,200
| +38% | +$18M |
|
|
FDO
114
DELISTED
FAMILY DOLLAR STORES
FDO
| $70.4M | 0.17% |
1,082,900
+1,020,300
| +1,630% | +$69.8M |
|
115
Tyler Technologies
TYL
$13.2B
| $70.3M | 0.17% |
687,900
+19,200
| +3% | +$1.86M |
|
116
Berkshire Hathaway Class B
BRK.B
$1.11T
| $69.8M | 0.17% |
589,100
+256,100
| +77% | +$29.6M |
|
|
ECHO
117
EchoStar
ECHO
$25.6B
| $68.7M | 0.16% |
1,704,006
+69,474
| +4% | +$2.72M |
|
|
SNTS
118
DELISTED
SANTARUS INC
SNTS
| $68.3M | 0.16% |
2,136,038
-6,900
| -0.3% | -$194K |
|
|
ENDP
119
DELISTED
Endo International plc
ENDP
| $67.8M | 0.16% |
1,005,693
+750,753
| +294% | +$42.8M |
|
|
MIC
120
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $66.9M | 0.16% |
1,228,900
+23,500
| +2% | +$1.28M |
|
|
SNDK
121
DELISTED
SANDISK CORP
SNDK
| $66.4M | 0.16% |
941,599
+897,400
| +2,030% | +$60.5M |
|
122
Baxter International
BAX
$14.3B
| $66.2M | 0.16% |
1,751,896
-1,585,837
| -48% | -$57.5M |
|
123
SBA Communications
SBAC
$19.3B
| $65.8M | 0.16% |
732,049
+491,200
| +204% | +$42.2M |
|
|
CPLA
124
DELISTED
Capella Education Company
CPLA
| $65.7M | 0.16% |
988,325
-21,600
| -2% | -$1.35M |
|
|
AZPN
125
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $65M | 0.16% |
1,555,334
+195,234
| +14% | +$8.16M |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.